Deepak Kilari

6PUBLICATIONS
88CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Mar 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.

Rana R McKay, Shayan S Nazari, Andrew Elliott

|Dec 05, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.

Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

|Dec 19, 2024
Non-clear cell renal cell carcinoma narrative review: where we are in 2024.

Michael J Pierro, Alexander Gallan, Deepak Kilari

|Dec 09, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.

Vadim S Koshkin, Nicholas Henderson, Marihella James

Pageof 1

Frequent Collaborators

4 joint publications

Pedro C Barata

3 joint publications

Vadim S Koshkin

3 joint publications

Rana R McKay

2 joint publications

Rohan Garje